Apple (AAPL) has hired a team of biomedical engineers as part of a secret initiative, initially envisioned by late Apple co-founder Steve Jobs, to develop sensors to treat diabetes, CNBC reported citing three people familiar with the matter.
An Apple spokeswoman declined to comment.
The engineers are expected to work at a nondescript office in Palo Alto, California, close to the corporate headquarters, CNBC said.
The news comes at the time when the line between pharmaceuticals and technology is blurring as companies are joining forces to tackle chronic diseases using high-tech devices that combine biology, software and hardware, thereby jump-starting a novel field of medicine called bioelectronics.
Last year, GlaxoSmithKline (GSK) and Google (GOOGL) parent Alphabet unveiled a joint company aimed at marketing bioelectronic devices to fight illness by attaching to individual nerves.
For more on biomedical technology, watch Fortune’s video:
U.S. biotech firms Setpoint Medical and EnteroMedics (ETRM) have already shown early benefits of bioelectronics in treating rheumatoid arthritis and suppressing appetite in the obese.
Other companies playing around the idea of bioelectronics include Medtronic (MDT) , Proteus Digital Technology , Sanofi SA (SNYNF) and Biogen (BIIB).
The company’s shares were marginally up after the bell on Wednesday.
